How Was Keytruda Studied for Cervical Cancer? Keytruda was studied in ... People in this trial got either pembrolizumab plus chemoradiotherapy (chemotherapy plus radiation) or placebo plus ...

All had locally advanced cervical cancer, although none had tumors that had spread to other organs. The control group ...

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Three prospective randomized trials comparing the efficacy of preoperative and postoperative chemoradiotherapy in locally advanced rectal cancer were initiated between 1993 and 1994. 4,5 Two of ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Keytruda (pembrolizumab) has been approved for use in combination with chemoradiotherapy (CRT) for patients with high-risk locally advanced cervical cancer; in other words, those with stage III to ...

Merck (MSD) has reported that the Phase III KEYNOTE-A18 (ENGOT-cx11/GOG-3047) clinical trial of KEYTRUDA plus chemoradiotherapy (CRT) in cervical cancer patients met the primary endpoint.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Read more about A trial looking at a drug called UCB4594 for cancer that has spread A trial looking at tolinapant and chemoradiotherapy for cervical cancer that has spread (CRAIN) This trial is ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...